CN101496861A - Traditional Chinese medicine for treating psoriasis - Google Patents
Traditional Chinese medicine for treating psoriasis Download PDFInfo
- Publication number
- CN101496861A CN101496861A CNA2009100081120A CN200910008112A CN101496861A CN 101496861 A CN101496861 A CN 101496861A CN A2009100081120 A CNA2009100081120 A CN A2009100081120A CN 200910008112 A CN200910008112 A CN 200910008112A CN 101496861 A CN101496861 A CN 101496861A
- Authority
- CN
- China
- Prior art keywords
- percent
- chinese medicine
- traditional chinese
- radix
- psoriasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a traditional Chinese medicine for treating psoriasis, and relates to the technical field of traditional Chinese medicine for treating psoriasis. The traditional Chinese medicine is prepared from the following raw material drugs in percentage by weight: 20 percent of gromwell root, 7 percent of roasted rhubarb, 17 percent of root of rehmannia, 7 percent of ophidian, 2 percent of cicada ecdysis, 13 percent of dragon's blood, 12 percent of scorpion, 2 percent of rhizoma atractylodis, 12 percent of radix codonopsitis, and 8 percent of tuckahoe. The traditional Chinese medicine for treating the psoriasis has the characteristics of short treatment course, quick effect, and little toxic and side effects.
Description
Technical field
The present invention relates to the psoriatic Chinese medicine of a kind of treatment.
Background technology
Its clinical manifestation of psoriasis is how hemorrhage with erythema, pimple, congestion, pruritus incrustation, chapped skin, pain, and comes off with a large amount of silvery whites or Lycoperdon polymorphum Vitt scurf.Psoriasis is having a strong impact on the healthy of people, and it is desquamation layer by layer, very itches unbearably erythema sheet sheet, outbreak repeatedly.At present the psoriatic Chinese medicine and western medicine of treatment has a variety ofly, but ubiquity course of treatment is long, slow, toxic side effect, Fa Zuo characteristics repeatedly take effect.
Summary of the invention
The object of the present invention is to provide a kind of short treating period, instant effect, the psoriatic Chinese medicine of treatment that toxic and side effects is little.
The present invention treats psoriatic Chinese medicine, and is formulated by following materials of weight proportions medicine: Radix Arnebiae (Radix Lithospermi) 20%, Radix Et Rhizoma Rhei (processed) 7%, the Radix Rehmanniae 17%, Zaocys 7%, Periostracum Cicadae 2%, Sanguis Draxonis 13%, Scorpio 12%, Rhizoma Atractylodis 2%, Radix Codonopsis 12%, Poria 8%.
Preparation method of the present invention is that above-mentioned materials of weight proportions medicine pulverize is made powder.Instructions of taking: once a day, morning one after each meal, each 5 the gram.
The present invention treats psoriatic Chinese medicine and has short treating period, instant effect, characteristics that toxic and side effects is little for curing psoriasis.
The specific embodiment
With crude drug Radix Arnebiae (Radix Lithospermi) 20 grams, Radix Et Rhizoma Rhei (processed) 7 grams, the Radix Rehmanniae 17 grams, Zaocys 7 grams, Periostracum Cicadae 2 grams, Sanguis Draxonis 13 grams, Scorpio 12 grams, Rhizoma Atractylodis 2 grams, Radix Codonopsis 12 grams, Poria 8 grams.Being ground into powder makes powder and promptly gets the present invention and treat psoriatic Chinese medicine.
Treatment by Chinese herbs psoriatic's of the present invention clinical trial.
1, physical data
Accept patient's 70 examples for medical treatment, wherein male 37 examples, women 33 examples, the age is 35-58 years old, above patient is homeliness type.
2, diagnostic criteria
Psoriasis is the most common with homeliness type, can be divided into for three phases, promptly carries out phase, resting stage, catagen.Clinical diagnosis characteristics performance: cover the silvery white squama of multilamellar on the erythema,, deviate from the shinny semi-transparent film of one deck pale red, mark thin film, sieve shape petechia is arranged with the squama blade coating.Pathological manifestations parakeratosis is diagnosis basis.The phase of carrying out, characteristics are that new skin lesion constantly occurs, and original skin lesion constantly enlarges, acute stage the skin lesion inflammation apparent in view, often show as cerise, be coated with above loose, come off easily silvery white squama, the periphery of skin lesion often have one the circle blush.Also claim stable phase resting stage, do not have newborn erythra, or less, and inflammation is not obvious, and blush alleviates, and the course of disease is long.
3, Therapeutic Method
Once a day, oral the present invention treats psoriatic Chinese powder medicine, each 5 grams.The stadium treatment was an observation caliber with 2-3 months.
4, curative effect determinate standard
Cure: skin lesion disappears, and the skin full recovery is normal.Produce effects: skin lesion disappears 70%-80%, and skin is most of to recover normal, only stays a little drop shape skin lesion.Invalid: taking medicine did not have significant change in 20 days.
5, result
Cure: 61 examples; Produce effects: 6 examples; Invalid: 3 examples.Cure rate reaches 87%, and total effective rate reaches 96%.
Claims (1)
1, the psoriatic Chinese medicine of a kind of treatment is characterized in that it is formulated by following materials of weight proportions medicine: Radix Arnebiae (Radix Lithospermi) 20%, Radix Et Rhizoma Rhei (processed) 7%, the Radix Rehmanniae 17%, Zaocys 7%, Periostracum Cicadae 2%, Sanguis Draxonis 13%, Scorpio 12%, Rhizoma Atractylodis 2%, Radix Codonopsis 12%, Poria 8%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100081120A CN101496861B (en) | 2009-02-28 | 2009-02-28 | Traditional Chinese medicine for treating psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100081120A CN101496861B (en) | 2009-02-28 | 2009-02-28 | Traditional Chinese medicine for treating psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101496861A true CN101496861A (en) | 2009-08-05 |
| CN101496861B CN101496861B (en) | 2011-03-23 |
Family
ID=40944270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100081120A Expired - Fee Related CN101496861B (en) | 2009-02-28 | 2009-02-28 | Traditional Chinese medicine for treating psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101496861B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101879224A (en) * | 2010-05-31 | 2010-11-10 | 毛瑞烽 | Oral administration medicament for treating psoriasis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1301736C (en) * | 2004-11-07 | 2007-02-28 | 宫世杰 | Poriasis treating Chinese medicine |
-
2009
- 2009-02-28 CN CN2009100081120A patent/CN101496861B/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101879224A (en) * | 2010-05-31 | 2010-11-10 | 毛瑞烽 | Oral administration medicament for treating psoriasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101496861B (en) | 2011-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102688360B (en) | Externally-applied skin medicine for treating burn and scald | |
| CN102114230B (en) | Medicament for treating psoriasis | |
| CN102106937A (en) | Medicament for treating psoriasis | |
| CN101658657B (en) | Drug for treating chronic cholecystitis | |
| CN101496861B (en) | Traditional Chinese medicine for treating psoriasis | |
| CN103479828A (en) | Formula of incised wound ointment, and preparation method of incised wound ointment | |
| CN102727695A (en) | Traditional Chinese medicinal medicine for treating hemafecia | |
| CN101919967B (en) | Traditional Chinese drug for treating esophagus cancer | |
| CN102784344B (en) | Traditional Chinese medicine preparation for treating pulmonary tuberculosis | |
| CN103893554A (en) | Tea oil medicinal preparation for treating skin burns and preparation method of preparation | |
| CN103041192A (en) | Bedsore paste | |
| CN1301736C (en) | Poriasis treating Chinese medicine | |
| CN103083618A (en) | Drug for treating gall-stone and preparation method of drug | |
| CN102688401B (en) | Traditional Chinese medicine oral liquid of couch grass root for treating chronic hepatitis and preparation method thereof | |
| CN102961634B (en) | External Chinese medicinal preparation for treating psoriasis and preparation method thereof | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN101229239B (en) | Chinese traditional medicine for treating psoriasis | |
| CN102697882A (en) | Angelica-containing Chinese medicinal oral liquid for treating chronic hepatitis and preparation method | |
| CN104208588A (en) | Traditional Chinese medicine preparation for treating tumor diseases and preparation method | |
| CN104435896A (en) | Navel patch | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN102698194B (en) | Virgate wormwood herb Chinese medicinal oral liquid for treating chronic hepatitis and preparation method | |
| CN102389462A (en) | Chinese medicine for treating cirrhosis | |
| CN110876792A (en) | Borneol plaster for relaxing muscles and tendons and activating collaterals | |
| CN101513485A (en) | Medicament for treating tinea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110323 Termination date: 20130228 |